Why Invest in NIH Research? | UMR Offers
Fact Sheets Explaining Why Congress Must #keepNIHstrong
Mark Your Calendars! | UMR's 2025 Annual Report is Coming Soon!
Rural State Analysis | UMR's 2023 Report Reveals the Exponential Impact of NIH Research Funding in 7 Rural States
Why Invest in NIH Research? | UMR Offers
Fact Sheets Explaining Why Congress Must #keepNIHstrong
Mark Your Calendars! | UMR's 2025 Annual Report is Coming Soon!
Rural State Analysis | UMR's 2023 Report Reveals the Exponential Impact of NIH Research Funding in 7 Rural States
Why Invest in NIH Research? | UMR Offers
Fact Sheets Explaining Why Congress Must #keepNIHstrong
MIT researchers in U.S. advance COVID-19 vaccine into preclinical tests
A research team at the Massachusetts Institute of Technology (MIT) in the US have advanced a Covid-19 vaccine candidate into preclinical tests in animal models. Led by professor Christopher Love from MIT’s Koch Institute for Iterative Cancer Research, the team worked to develop preclinical materials for rapid progress of the candidate to clinical trials.
